Rakuten Investment Management, Inc.
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 2062680
TOKYO, M0
Position in VRTX
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$30,391,431
+$6,863,239 QoQ
Shares Held
61,183
+16.1% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#209
of 1,735 holders
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rakuten Investment Management, Inc. holds $59,330,921 across 7 Biotechnology names. VRTX ranks #1 (51.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
61,183 | $30,391,431 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
24,580 | $15,326,613 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
17,961 | $5,406,799 | |
| 4 | INCY |
Incyte Corp
|
27,525 | $3,120,234 | |
| 5 | MRNA |
Moderna, Inc.
|
37,441 | $2,621,993 | |
| 6 | INSM |
INSMED Inc
|
12,109 | $1,291,061 | |
| 7 | TECH |
BIO-TECHNE Corp
|
16,600 | $1,172,790 |
All Filings in VRTX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30,391,431 | 61,183 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $23,528,192 | 52,690 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $21,391,791 | 47,185 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $94,957,817 | 242,462 | Shares | Sole | 2025-10-30 | |
| 2025-03-31 | $15,936,518 | 32,871 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $9,531,814 | 20,495 | Shares | Sole | 2025-05-15 | |
| 2024-06-30 | $7,137,668 | 15,228 | Shares | Sole | 2025-05-15 | |
| 2024-03-31 | $3,932,220 | 9,407 | Shares | Sole | 2025-05-15 | |
| 2023-12-31 | $259,188 | 637 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||